Navigation Links
Society for Biomolecular Sciences Announces 2008 Conference Speaker Line-up
Date:3/19/2008

Leaders in Biotechnology and Drug Development to Attend April Meeting in St. Louis

DANBURY, Conn., March 19 /PRNewswire-USNewswire/ -- The Society for Biomolecular Sciences (SBS) today announced its outstanding roster of keynote speakers for its 14th Annual Conference & Exhibition to be held April 6-10 at America's Center in St. Louis, MO. More than 2,500 leaders in the pharmaceutical and biotech industries from around the world are expected to attend the 2008 Conference to discuss advances in biotechnology, challenges and automation solutions in the field.

Leading presentations for the five-day event will be Janet Woodcock, M.D., deputy commissioner and chief medical officer for the U.S. Food & Drug Administration. Dr. Woodcock, who oversees scientific and medical regulatory operations for the FDA, will speak on "The Promise of Molecular Medicine." Dr. Woodcock most recently served as the FDA's Deputy Commissioner for Operations and Chief Operating Officer and as the Director of the FDA's Center for Drug Evaluation.

Joining Dr. Woodcock as a keynote speaker will be Jonathan D. Gitlin, M.D., the Helene B. Roberson Professor of Pediatrics and Professor of Genetics at the Washington University School of Medicine. Dr. Gitlin's speech entitled "Child Health Research in the 21st Century: Obstacles and Opportunities," will address whether diseases such as Alzheimer's, diabetes and obesity are already genetically encoded in individuals while still in the womb, and can possibly be prevented with genetic engineering before birth.

Completing the keynote speaker line-up will be Jeffrey I. Gordon, M.D., the Robert J. Glaser Distinguished University Professor at Washington University School of Medicine. Dr. Gordon's speech is entitled "Dining in With a Few Trillion Friends: Exploring the Human Gut Microbiota and Microbiome." Dr. Gordon has also served as the head of molecular biology and pharmacology at Washington University School of Medicine and was director of the University's division of biology and biomedical sciences.

The Society for Biomolecular Sciences (SBS) is the only international non-profit scientific society dedicated to drug discovery and its related disciplines. Founded in 1994, the Society provides a forum for global education and information exchange among professionals in the chemical, pharmaceutical, biotech and agrochemical industries. SBS was developed in an effort to advance the science of drug discovery and related disciplines by providing a forum for education and information exchange among professionals around the world.

For further information on the SBS 14th Annual Conference and Exhibition, visit http://www.sbsonline.org or contact Jennifer Bender or Rosalind D'Eugenio at (203) 325-8772, or jbender@environics-usa.com.


'/>"/>
SOURCE Society for Biomolecular Sciences
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. News from the March 2008 American Physical Society Meeting
2. Professor Toh-Ming Lu named fellow of the Materials Research Society
3. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
4. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
5. Complete ANX-530 Safety Data to be Published in the 2008 Proceedings of the American Society of Clinical Oncology
6. Society for Biological Engineering Holds First International Conference on Stem Cell Engineering
7. Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics
8. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
9. 49th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases
10. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
11. Three Astex Drug Candidates to be Presented at the 2007 American Society of Hematology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... -- --> --> Q ... to provide the following update on recent corporate developments. ... 3 months we have significantly increased our cash position through ... a result, we have positioned ourselves to execute on the ... expect that development to continue on schedule. ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... supplier of Semantic Graph Database technology has been recognized As “ Best in ... Corporate America Magazine. , “At Corporate America, it’s our priority to showcase prominent ...
(Date:2/3/2016)... WARRINGTON, Pa. , Feb. 3, 2016 /PRNewswire/ ... biotechnology company focused on developing aerosolized KL4 surfactant ... Board of Directors has approved an inducement award ... Craig Fraser , its newly appointed President and ... the Board,s Compensation Committee on February 1, 2016 ...
(Date:2/3/2016)... N.J. , Feb. 3, 2016 ... totaling more than $1 million for researchers in ... working on health-related research that demonstrates exciting potential. ... round of funding for the New Jersey Health Foundation ... faculty members at these educational institutions— Princeton University, ...
Breaking Biology Technology:
(Date:2/3/2016)... --> --> Fourth quarter ... up 1,187% compared with fourth quarter of 2014. Gross margin ... (loss: 30.0). Earnings per share increased to SEK 6.39 (loss: ... (neg: 74.7). , --> --> ... 2,900.5 M (233.6), up 1,142% compared with 2014. Gross margin ...
(Date:2/3/2016)... DUBLIN , Feb. 3, 2016 /PRNewswire/ ... announced the addition of the "Emotion ... NLP, Machine Learning, and Others), Software Tools ... Application Areas, End Users,and Regions - Global ... offering. --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) ...
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
Breaking Biology News(10 mins):